Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: low-grade fever; mild to intense headache; muscles soreness; fatigue; on and off sweats; chills; difficulty sleeping; mild soreness at the injection site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 27-year-old female patient received BNT162b2 (BNT162B2), on 19Nov2021 at 10:45 as dose 3 (booster), single (Lot number: FH8030) at the age of 27 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: BLISOVI 24 FE oral taken for contraception, start date: 2018 (ongoing). Vaccination history included: BNT162b2 (DOSE 1; Lot number: EL3247; 10:00 in right arm), administration date: 04Mar2021, when the patient was 26-year-old, for COVID-19 immunization, reaction(s): "low-grade fever", "mild to intense headache", "muscles soreness", "fatigue", "on and off sweats", "chills", "difficulty sleeping", "mild soreness at the injection site"; BNT162b2 (DOSE 2; Lot number: EP6955; 09:30 in right arm), administration date: 25Mar2021, when the patient was 26-year-old, for COVID-19 immunization, reaction(s): "low-grade fever", "mild to intense headache", "muscles soreness", "fatigue", "on and off sweats", "chills", "difficulty sleeping", "mild soreness at the injection site". The following information was reported: CHILLS (non-serious) with onset 19Nov2021 at 21:00, outcome "recovered"; INSOMNIA (non-serious) with onset 19Nov2021 at 21:00, outcome "recovered", described as "difficulty sleeping"; FATIGUE (non-serious) with onset 19Nov2021 at 21:00, outcome "recovered"; PYREXIA (non-serious) with onset 19Nov2021 at 21:00, outcome "recovered", described as "low-grade fever"; VACCINATION SITE PAIN (non-serious) with onset 19Nov2021 at 21:00, outcome "recovered", described as "mild soreness at the injection site"; HEADACHE (non-serious) with onset 19Nov2021 at 21:00, outcome "recovered", described as "mild to intense headache"; MYALGIA (non-serious) with onset 19Nov2021 at 21:00, outcome "recovered", described as "muscles soreness"; HYPERHIDROSIS (non-serious) with onset 19Nov2021 at 21:00, outcome "recovered", described as "on and off sweats". Therapeutic measures were taken as a result of pyrexia, headache, myalgia, fatigue, hyperhidrosis, chills, vaccination site pain.  Additional information: Following vaccination (primary dose, second dose, and both boosters),  the patient experienced a low-grade fever, mild to intense headache, muscles soreness and fatigue, on and off sweats/chills, difficulty sleeping due to side effects after getting the vaccine, and mild soreness at the injection site. The onset of side effects began in the evening and continued through the night and into the next day. The patient recalls that the side effects following the 3rd (booster) dose were the most severe and lasted more than 24 hours. She took acetaminophen in all instances as recommended and recovered.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300029954 same patient/events, different dose;US-PFIZER INC-2021336635 same patient/events, different dose;